 |
GENEVA, Aug. 10, 2022 /PRNewswire/ -- SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial femoral artery (SFA).
MedAlliance SELUTION SLR Receives Second...Read more: MedAlliance SELUTION SLR Receives Second FDA IDE Approval
Hashtag.net.au
For many people, dental anxiety isn’t just a minor worry — it’s a barrier that keeps them from getting the care they need. The sound of drills, the sterile scent, or even a simple check-up can cause h...
Hashtag.net.au
Getting a restful night's sleep is essential for overall health and well-being. For many, external noises—be it a snoring partner, traffic, or noisy neighbors—can disrupt sleep patterns. One effective...
Hashtag.net.au
Adolescence is often described as a turbulent period of life. Hormonal changes, social pressures, academic stress, and the search for identity all combine to make the teenage years emotionally inten...